Pablo Legorreta, chief executive and founder of Royalty Pharma

Pablo Legorreta is down but not out. The man behind the high profile and often crabby campaign to acquire Ireland’s largest indigenous pharma group El(...)

Elan chairman Robert Ingram at the company’s EGM in Dublin today. Photograph: Aidan Crawley

Elan shareholders decisively rejected a major investment programme proposed by the company at a special meeting in Dublin today.However, investors nar(...)

Royalty Pharma’s hostile bid for Irish pharmaceutical firm Elan continues as its chairman asserts that “no other bona fide buyer” is interested in Elan. (Photo:John Cogill/Bloomberg News)

Ahead of Elan’s egm later today, at which shareholders will vote on a series of acquisitions undertaken by the Irish pharmaceutical firm, the chairman(...)

Drug company Elan last night dropped a legal action in New York against Royalty Pharmaceuticals, the company locked in a €6.7 billion takeover battle (...)